INVO Fertility (IVF) Cash & Equivalents (2010 - 2025)

INVO Fertility has disclosed Cash & Equivalents across 16 years of filings, most recently posting $400000.0 for Q3 2025.

• Quarterly Cash & Equivalents fell 15.18% year-over-year to $400000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $400000.0 (down 15.18% YoY) and the FY2024 annual result came in at $741396.0, up 218.98% from the prior year.
• Cash & Equivalents retreated to $400000.0 in Q3 2025, from $549181.0 in the prior quarter.
• Across five years, Cash & Equivalents topped out at $8.4 million in Q1 2021 and bottomed at $90135.0 in Q4 2022.
• The 5-year median for Cash & Equivalents is $840407.0 (2025), against an average of $2.1 million.
• Year-over-year, Cash & Equivalents jumped 2306.64% in 2021 and plunged 98.41% in 2022.
• INVO Fertility's Cash & Equivalents stood at $5.7 million in 2021, then plunged by 98.41% to $90135.0 in 2022, then soared by 157.86% to $232424.0 in 2023, then soared by 218.98% to $741396.0 in 2024, then tumbled by 46.05% to $400000.0 in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $400000.0, $549181.0, and $840407.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.